世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

経皮パッチの世界市場規模、メーカー、サプライチェーン、販売チャネル、顧客、2025-2031年

経皮パッチの世界市場規模、メーカー、サプライチェーン、販売チャネル、顧客、2025-2031年


Global Transdermal Patch Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

2024年の経皮パッチの世界市場規模は7億2,800万米ドルと推定され、予測期間2025-2031年の年平均成長率は3.6%で、2031年には約9億3,200万米ドルに達すると予測されている。 経皮パッチには、フェンタニル経皮... もっと見る

 

 

出版社 出版年月 電子版価格 納期 言語
QYResearch
QYリサーチ
2025年5月13日 US$5,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
5-7営業日 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

2024年の経皮パッチの世界市場規模は7億2,800万米ドルと推定され、予測期間2025-2031年の年平均成長率は3.6%で、2031年には約9億3,200万米ドルに達すると予測されている。

経皮パッチには、フェンタニル経皮パッチ、ニコチン経皮パッチ、ブプレノルフィン経皮パッチ、クロニジン経皮パッチ、オキシブチニン経皮パッチ、エストラジオール経皮パッチ、ニトログリセリン経皮パッチなどが含まれる。

経皮吸収パッチは主に以下のタイプに分類される:サリチル酸メチル系パッチ、リバスチグミン系パッチ、フェンタニル系パッチ、リドカイン系パッチ、ジクロフェナク系パッチ、ニコチン系パッチなどである。サリチル酸メチル系が18%で市場の大部分を占め、次いでリドカインパッチが15%である。
経皮吸収パッチはRxチャンネルとOTCチャンネルを通じて薬物を供給することができる。市場シェアは前者の方が大きく、販売量は全体の約76%を占めている。
久光製薬、ジョンソン・エンド・ジョンソン、日東電工、マイランが経皮パッチの世界市場トップ4である。彼らは2019年に世界市場の約42%を占めた。

レポートの範囲
当レポートは、経皮吸収パッチの世界市場を定量的・定性的分析の両面から包括的に紹介することで、読者のビジネス/成長戦略の策定、市場競争状況の評価、現在の市場における自社の位置づけの分析、経皮吸収パッチに関する十分な情報に基づいたビジネス上の意思決定の一助となることを目的としています。
経皮吸収パッチの市場規模、推計、予測は、2024年を基準年として、2020年から2031年までの期間の履歴データと予測データとともに、販売数量(百万枚)と収益(百万ドル)で提供されます。本レポートでは、世界の経皮吸収パッチ市場を包括的に区分しています。製品タイプ別、用途別、プレイヤー別の地域別市場規模も掲載しています。
市場のより詳細な理解のために、競合状況、主要競合企業のプロフィール、それぞれの市場ランクを掲載しています。また、技術動向や新製品開発についても論じています。
本レポートは、企業別、タイプ別、用途別、地域別など、さまざまなセグメントにわたる市場全体とサブセグメントの収益、販売量、平均価格に関する情報を提供し、本市場における経皮吸収パッチメーカー、新規参入企業、産業チェーン関連企業の助けとなります。

企業別
久光製薬
ジョンソン・エンド・ジョンソン
ノバルティス
UCBファーマ
マイラン
テバ製薬
日東電工
グリュネンタール
IBSAグループ
GSK
Luye Pharmaグループ
ファイザー
チャテム
ドクター・レディーズ・ラボラトリーズ
バイエル
ムンディファーマ
遠藤インターナショナル
北京タイド製薬
タイプ別セグメント
サリチル酸メチルベースのパッチ
リバスチグミン経皮吸収パッチ
フェンタニル経皮吸収パッチ
リドカインパッチ
ジクロフェナクパッチ
ニコチン経皮吸収パッチ
その他
用途別セグメント
Rxチャンネル
OTCチャネル
地域別
北米
米国
カナダ
アジア太平洋
中国
日本
韓国
インド
東南アジア
オーストラリア
その他のアジア太平洋地域
欧州
ドイツ
フランス
英国
イタリア
ロシア
北欧諸国
その他のヨーロッパ
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他のMEA

各章の概要
第1章: レポートのスコープ、各市場セグメント(タイプ別、用途別など)の市場規模、今後の発展可能性などのエグゼクティブサマリーを紹介。市場の現状と、短期・中期・長期的な展開の可能性について、ハイレベルな見解を提供しています。
第2章:経皮吸収型テープ製剤の世界および地域レベルでの販売(消費)、収益。各地域とその主要国の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間を紹介しています。
第3章:経皮吸収パッチメーカーの競争環境、価格、売上高、市場シェア、業界ランキング、最新の開発計画、合併・買収情報などを詳細に分析。
第4章:主要メーカーのプロフィールを提供し、製品の説明と仕様、経皮パッチの売上高、収益、価格、粗利益率、地域別、タイプ別、用途別の売上高、最近の開発状況など、市場の主要企業の基本状況を詳しく紹介する。
第5章:タイプ別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。
第6章:用途別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展可能性をカバーし、読者が異なる下流市場のブルーオーシャン市場を見つけるのを助ける。
第7章:北米:タイプ別、用途別、国別、セグメント別の売上高、収益。
第8章:APAC:タイプ別、用途別、国別、セグメント別の売上高と収益。
第9章:ヨーロッパ:タイプ別、用途別、国別、セグメント別の売上高と収益。
第10章:ラテンアメリカ:タイプ別、用途別、国別、セグメント別の売上高と収益。
第11章:中東・アフリカ:タイプ別、用途別、国別、セグメント別の売上高、収益
第12章:産業チェーン、販売チャネル、主要原材料、流通業者、顧客の分析。
第13章:市場力学、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を紹介する。
第14章:調査結果と結論。


ページTOPに戻る


目次

1 Study Coverage
1.1 Transdermal Patch Product Introduction
1.2 Market by Type
1.2.1 Global Transdermal Patch Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Methyl Salicylate-based Patch
1.2.3 Rivastigmine Transdermal Patch
1.2.4 Fentanyl Transdermal Patch
1.2.5 Lidocaine Patch
1.2.6 Diclofenac Patch
1.2.7 Nicotine Transdermal Patch
1.2.8 Others
1.3 Market by Application
1.3.1 Global Transdermal Patch Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Rx Channel
1.3.3 OTC Channel
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Transdermal Patch Market Size Estimates and Forecasts
2.1.1 Global Transdermal Patch Revenue 2020-2031
2.1.2 Global Transdermal Patch Sales 2020-2031
2.2 Transdermal Patch Market Size by Region: 2024 Versus 2031
2.3 Transdermal Patch Sales by Region (2020-2031)
2.3.1 Global Transdermal Patch Sales by Region: 2020-2025
2.3.2 Global Transdermal Patch Sales Forecast by Region (2026-2031)
2.3.3 Global Transdermal Patch Sales Market Share by Region (2020-2031)
2.4 Transdermal Patch Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Transdermal Patch Revenue by Region: 2020-2025
2.4.2 Global Transdermal Patch Revenue Forecast by Region (2026-2031)
2.4.3 Global Transdermal Patch Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Transdermal Patch Sales by Type (2020-2031)
3.1.1.1 Global Transdermal Patch Sales Volume by Type (2020-2031)
3.1.1.2 Global Transdermal Patch Sales Market Share by Type (2020-2031)
3.1.2 Global Transdermal Patch Revenue by Type (2020-2031)
3.1.2.1 Global Transdermal Patch Revenue by Type (2020-2031)
3.1.2.2 Global Transdermal Patch Revenue Market Share by Type (2020-2031)
3.1.3 Transdermal Patch Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Transdermal Patch Sales by Application (2020-2031)
3.2.1.1 Global Transdermal Patch Sales Volume by Application (2020-2031)
3.2.1.2 Global Transdermal Patch Sales Market Share by Application (2020-2031)
3.2.2 Global Transdermal Patch Revenue by Application (2020-2031)
3.2.2.1 Global Transdermal Patch Revenue by Application (2020-2031)
3.2.2.2 Global Transdermal Patch Revenue Market Share by Application (2020-2031)
3.2.3 Transdermal Patch Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Methyl Salicylate-based Patch of Transdermal Patch Revenue Market Share by Application
3.3.2 Rivastigmine Transdermal Patch of Transdermal Patch Revenue Market Share by Application
3.3.3 Fentanyl Transdermal Patch of Transdermal Patch Revenue Market Share by Application
3.3.4 Lidocaine Patch of Transdermal Patch Revenue Market Share by Application
3.3.5 Diclofenac Patch of Transdermal Patch Revenue Market Share by Application
3.3.6 Nicotine Transdermal Patch of Transdermal Patch Revenue Market Share by Application
3.3.7 Others of Transdermal Patch Revenue Market Share by Application
4 Global Transdermal Patch by Manufacturers
4.1 Global Top Transdermal Patch Manufacturers by Sales (2020-2025)
4.1.1 Global Transdermal Patch Sales by Manufacturer (2020-2025)
4.1.2 Global Transdermal Patch Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Transdermal Patch Manufacturers by Revenue (2020-2025)
4.2.1 Global Transdermal Patch Revenue by Manufacturer (2020-2025)
4.2.2 Global Transdermal Patch Revenue Share by Manufacturer (2020-2025)
4.3 Global Transdermal Patch Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Transdermal Patch Manufacturers Covered: Ranking by Revenue
4.4.2 Global Transdermal Patch Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Transdermal Patch Manufacturing Base Distribution, Product Type
4.5.1 Transdermal Patch Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Transdermal Patch Market
4.5.3 Manufacturers Transdermal Patch Product Type and Application
4.5.4 Methyl Salicylate-based Patch Market Sales of Transdermal Patch by Manufacturer
4.5.5 Rivastigmine Transdermal Patch Market Sales of Transdermal Patch by Manufacturer
4.5.6 Fentanyl Transdermal Patch Market Sales of Transdermal Patch by Manufacturer
4.5.7 Lidocaine Patch Market Sales of Transdermal Patch by Manufacturer
4.5.8 Diclofenac Patch Market Sales of Transdermal Patch by Manufacturer
4.5.9 Nicotine Transdermal Patch Market Sales of Transdermal Patch by Manufacturer
4.5.10 Others Market Sales of Transdermal Patch by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Hisamitsu Pharmaceutical
5.1.1 Hisamitsu Pharmaceutical Company Information
5.1.2 Hisamitsu Pharmaceutical Description, Business Overview
5.1.3 Hisamitsu Pharmaceutical Transdermal Patch Products Offered
5.1.4 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Hisamitsu Pharmaceutical Transdermal Patch Sales by Product in 2024
5.1.6 Hisamitsu Pharmaceutical Transdermal Patch Sales by Application in 2024
5.1.7 Hisamitsu Pharmaceutical Transdermal Patch Sales by Geographic Area in 2024
5.1.8 Hisamitsu Pharmaceutical Recent Developments
5.2 Johnson & Johnson
5.2.1 Johnson & Johnson Company Information
5.2.2 Johnson & Johnson Description, Business Overview
5.2.3 Johnson & Johnson Transdermal Patch Products Offered
5.2.4 Johnson & Johnson Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Johnson & Johnson Transdermal Patch Sales by Product in 2024
5.2.6 Johnson & Johnson Transdermal Patch Sales by Application in 2024
5.2.7 Johnson & Johnson Transdermal Patch Sales by Geographic Area in 2024
5.2.8 Johnson & Johnson Recent Developments
5.3 Novartis
5.3.1 Novartis Company Information
5.3.2 Novartis Description, Business Overview
5.3.3 Novartis Transdermal Patch Products Offered
5.3.4 Novartis Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Novartis Transdermal Patch Sales by Product in 2024
5.3.6 Novartis Transdermal Patch Sales by Application in 2024
5.3.7 Novartis Transdermal Patch Sales by Geographic Area in 2024
5.3.8 Novartis Recent Developments
5.4 UCB Pharma
5.4.1 UCB Pharma Company Information
5.4.2 UCB Pharma Description, Business Overview
5.4.3 UCB Pharma Transdermal Patch Products Offered
5.4.4 UCB Pharma Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.4.5 UCB Pharma Transdermal Patch Sales by Product in 2024
5.4.6 UCB Pharma Transdermal Patch Sales by Application in 2024
5.4.7 UCB Pharma Transdermal Patch Sales by Geographic Area in 2024
5.4.8 UCB Pharma Recent Developments
5.5 Mylan
5.5.1 Mylan Company Information
5.5.2 Mylan Description, Business Overview
5.5.3 Mylan Transdermal Patch Products Offered
5.5.4 Mylan Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Mylan Transdermal Patch Sales by Product in 2024
5.5.6 Mylan Transdermal Patch Sales by Application in 2024
5.5.7 Mylan Transdermal Patch Sales by Geographic Area in 2024
5.5.8 Mylan Recent Developments
5.6 Teva Pharmaceutical
5.6.1 Teva Pharmaceutical Company Information
5.6.2 Teva Pharmaceutical Description, Business Overview
5.6.3 Teva Pharmaceutical Transdermal Patch Products Offered
5.6.4 Teva Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Teva Pharmaceutical Transdermal Patch Sales by Product in 2024
5.6.6 Teva Pharmaceutical Transdermal Patch Sales by Application in 2024
5.6.7 Teva Pharmaceutical Transdermal Patch Sales by Geographic Area in 2024
5.6.8 Teva Pharmaceutical Recent Developments
5.7 Nitto Denko
5.7.1 Nitto Denko Company Information
5.7.2 Nitto Denko Description, Business Overview
5.7.3 Nitto Denko Transdermal Patch Products Offered
5.7.4 Nitto Denko Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Nitto Denko Transdermal Patch Sales by Product in 2024
5.7.6 Nitto Denko Transdermal Patch Sales by Application in 2024
5.7.7 Nitto Denko Transdermal Patch Sales by Geographic Area in 2024
5.7.8 Nitto Denko Recent Developments
5.8 Grünenthal
5.8.1 Grünenthal Company Information
5.8.2 Grünenthal Description, Business Overview
5.8.3 Grünenthal Transdermal Patch Products Offered
5.8.4 Grünenthal Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Grünenthal Transdermal Patch Sales by Product in 2024
5.8.6 Grünenthal Transdermal Patch Sales by Application in 2024
5.8.7 Grünenthal Transdermal Patch Sales by Geographic Area in 2024
5.8.8 Grünenthal Recent Developments
5.9 IBSA Group
5.9.1 IBSA Group Company Information
5.9.2 IBSA Group Description, Business Overview
5.9.3 IBSA Group Transdermal Patch Products Offered
5.9.4 IBSA Group Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.9.5 IBSA Group Transdermal Patch Sales by Product in 2024
5.9.6 IBSA Group Transdermal Patch Sales by Application in 2024
5.9.7 IBSA Group Transdermal Patch Sales by Geographic Area in 2024
5.9.8 IBSA Group Recent Developments
5.10 GSK
5.10.1 GSK Company Information
5.10.2 GSK Description, Business Overview
5.10.3 GSK Transdermal Patch Products Offered
5.10.4 GSK Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.10.5 GSK Transdermal Patch Sales by Product in 2024
5.10.6 GSK Transdermal Patch Sales by Application in 2024
5.10.7 GSK Transdermal Patch Sales by Geographic Area in 2024
5.10.8 GSK Recent Developments
5.11 Luye Pharma Group
5.11.1 Luye Pharma Group Company Information
5.11.2 Luye Pharma Group Description, Business Overview
5.11.3 Luye Pharma Group Transdermal Patch Products Offered
5.11.4 Luye Pharma Group Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Luye Pharma Group Transdermal Patch Sales by Product in 2024
5.11.6 Luye Pharma Group Transdermal Patch Sales by Application in 2024
5.11.7 Luye Pharma Group Transdermal Patch Sales by Geographic Area in 2024
5.11.8 Luye Pharma Group Recent Developments
5.12 Pfizer
5.12.1 Pfizer Company Information
5.12.2 Pfizer Description, Business Overview
5.12.3 Pfizer Transdermal Patch Products Offered
5.12.4 Pfizer Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Pfizer Transdermal Patch Sales by Product in 2024
5.12.6 Pfizer Transdermal Patch Sales by Application in 2024
5.12.7 Pfizer Transdermal Patch Sales by Geographic Area in 2024
5.12.8 Pfizer Recent Developments
5.13 Chattem
5.13.1 Chattem Company Information
5.13.2 Chattem Description, Business Overview
5.13.3 Chattem Transdermal Patch Products Offered
5.13.4 Chattem Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Chattem Transdermal Patch Sales by Product in 2024
5.13.6 Chattem Transdermal Patch Sales by Application in 2024
5.13.7 Chattem Transdermal Patch Sales by Geographic Area in 2024
5.13.8 Chattem Recent Developments
5.14 Dr Reddy’s Laboratories
5.14.1 Dr Reddy’s Laboratories Company Information
5.14.2 Dr Reddy’s Laboratories Description, Business Overview
5.14.3 Dr Reddy’s Laboratories Transdermal Patch Products Offered
5.14.4 Dr Reddy’s Laboratories Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.14.5 Dr Reddy’s Laboratories Transdermal Patch Sales by Product in 2024
5.14.6 Dr Reddy’s Laboratories Transdermal Patch Sales by Application in 2024
5.14.7 Dr Reddy’s Laboratories Transdermal Patch Sales by Geographic Area in 2024
5.14.8 Dr Reddy’s Laboratories Recent Developments
5.15 Bayer
5.15.1 Bayer Company Information
5.15.2 Bayer Description, Business Overview
5.15.3 Bayer Transdermal Patch Products Offered
5.15.4 Bayer Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.15.5 Bayer Transdermal Patch Sales by Product in 2024
5.15.6 Bayer Transdermal Patch Sales by Application in 2024
5.15.7 Bayer Transdermal Patch Sales by Geographic Area in 2024
5.15.8 Bayer Recent Developments
5.16 Mundipharma
5.16.1 Mundipharma Company Information
5.16.2 Mundipharma Description, Business Overview
5.16.3 Mundipharma Transdermal Patch Products Offered
5.16.4 Mundipharma Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.16.5 Mundipharma Transdermal Patch Sales by Product in 2024
5.16.6 Mundipharma Transdermal Patch Sales by Application in 2024
5.16.7 Mundipharma Transdermal Patch Sales by Geographic Area in 2024
5.16.8 Mundipharma Recent Developments
5.17 Endo International
5.17.1 Endo International Company Information
5.17.2 Endo International Description, Business Overview
5.17.3 Endo International Transdermal Patch Products Offered
5.17.4 Endo International Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.17.5 Endo International Transdermal Patch Sales by Product in 2024
5.17.6 Endo International Transdermal Patch Sales by Application in 2024
5.17.7 Endo International Transdermal Patch Sales by Geographic Area in 2024
5.17.8 Endo International Recent Developments
5.18 Beijing Tide Pharmaceutical
5.18.1 Beijing Tide Pharmaceutical Company Information
5.18.2 Beijing Tide Pharmaceutical Description, Business Overview
5.18.3 Beijing Tide Pharmaceutical Transdermal Patch Products Offered
5.18.4 Beijing Tide Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.18.5 Beijing Tide Pharmaceutical Transdermal Patch Sales by Product in 2024
5.18.6 Beijing Tide Pharmaceutical Transdermal Patch Sales by Application in 2024
5.18.7 Beijing Tide Pharmaceutical Transdermal Patch Sales by Geographic Area in 2024
5.18.8 Beijing Tide Pharmaceutical Recent Developments
6 North America
6.1 North America Transdermal Patch Market Size YoY Growth 2020-2031
6.2 North America Transdermal Patch Market Facts & Figures by Country
6.2.1 North America Transdermal Patch Sales by Country (2020-2031)
6.2.2 North America Transdermal Patch Revenue by Country (2020-2031)
6.3 North America Transdermal Patch Sales by Type (2020-2025)
6.4 North America Transdermal Patch Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Transdermal Patch Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Transdermal Patch Market Facts & Figures by Region
7.2.1 Asia-Pacific Transdermal Patch Sales by Region (2020-2031)
7.2.2 Asia-Pacific Transdermal Patch Revenue by Region (2020-2031)
7.3 Asia-Pacific Transdermal Patch Sales by Type (2020-2025)
7.4 Asia-Pacific Transdermal Patch Sales by Application (2020-2025)
8 Europe
8.1 Europe Transdermal Patch Market Size YoY Growth 2020-2031
8.2 Europe Transdermal Patch Market Facts & Figures by Country
8.2.1 Europe Transdermal Patch Sales by Country (2020-2031)
8.2.2 Europe Transdermal Patch Revenue by Country (2020-2031)
8.3 Europe Transdermal Patch Sales by Type (2020-2025)
8.4 Europe Transdermal Patch Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Transdermal Patch Market Size YoY Growth 2020-2031
9.2 Latin America Transdermal Patch Market Facts & Figures by Country
9.2.1 Latin America Transdermal Patch Sales by Country (2020-2031)
9.2.2 Latin America Transdermal Patch Revenue by Country (2020-2031)
9.3 Latin America Transdermal Patch Sales by Type (2020-2025)
9.4 Latin America Transdermal Patch Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Transdermal Patch Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Transdermal Patch Market Facts & Figures by Country
10.2.1 Middle East and Africa Transdermal Patch Sales by Country (2020-2031)
10.2.2 Middle East and Africa Transdermal Patch Revenue by Country (2020-2031)
10.3 Middle East and Africa Transdermal Patch Sales by Type (2020-2025)
10.4 Middle East and Africa Transdermal Patch Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Transdermal Patch Supply Chain Analysis
11.2 Transdermal Patch Key Raw Materials and Upstream Suppliers
11.3 Transdermal Patch Clients Analysis
11.4 Transdermal Patch Sales Channel and Sales Model Analysis
11.4.1 Transdermal Patch Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Transdermal Patch Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Transdermal Patch Distributors
12 Transdermal Patch Market Dynamics
12.1 Transdermal Patch Industry Trends
12.2 Transdermal Patch Market Drivers
12.3 Transdermal Patch Market Challenges
12.4 Transdermal Patch Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

 

ページTOPに戻る


 

Summary

In 2024, the global market size of Transdermal Patch was estimated to be worth US$ 7287 million and is forecast to reach approximately US$ 9302 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.
Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total.
Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Transdermal Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Patch.
The Transdermal Patch market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transdermal Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transdermal Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

By Company
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Grünenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy’s Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical
Segment by Type
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Segment by Application
Rx Channel
OTC Channel
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Transdermal Patch in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Transdermal Patch manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transdermal Patch sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Transdermal Patch Product Introduction
1.2 Market by Type
1.2.1 Global Transdermal Patch Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Methyl Salicylate-based Patch
1.2.3 Rivastigmine Transdermal Patch
1.2.4 Fentanyl Transdermal Patch
1.2.5 Lidocaine Patch
1.2.6 Diclofenac Patch
1.2.7 Nicotine Transdermal Patch
1.2.8 Others
1.3 Market by Application
1.3.1 Global Transdermal Patch Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Rx Channel
1.3.3 OTC Channel
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Transdermal Patch Market Size Estimates and Forecasts
2.1.1 Global Transdermal Patch Revenue 2020-2031
2.1.2 Global Transdermal Patch Sales 2020-2031
2.2 Transdermal Patch Market Size by Region: 2024 Versus 2031
2.3 Transdermal Patch Sales by Region (2020-2031)
2.3.1 Global Transdermal Patch Sales by Region: 2020-2025
2.3.2 Global Transdermal Patch Sales Forecast by Region (2026-2031)
2.3.3 Global Transdermal Patch Sales Market Share by Region (2020-2031)
2.4 Transdermal Patch Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Transdermal Patch Revenue by Region: 2020-2025
2.4.2 Global Transdermal Patch Revenue Forecast by Region (2026-2031)
2.4.3 Global Transdermal Patch Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Transdermal Patch Sales by Type (2020-2031)
3.1.1.1 Global Transdermal Patch Sales Volume by Type (2020-2031)
3.1.1.2 Global Transdermal Patch Sales Market Share by Type (2020-2031)
3.1.2 Global Transdermal Patch Revenue by Type (2020-2031)
3.1.2.1 Global Transdermal Patch Revenue by Type (2020-2031)
3.1.2.2 Global Transdermal Patch Revenue Market Share by Type (2020-2031)
3.1.3 Transdermal Patch Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Transdermal Patch Sales by Application (2020-2031)
3.2.1.1 Global Transdermal Patch Sales Volume by Application (2020-2031)
3.2.1.2 Global Transdermal Patch Sales Market Share by Application (2020-2031)
3.2.2 Global Transdermal Patch Revenue by Application (2020-2031)
3.2.2.1 Global Transdermal Patch Revenue by Application (2020-2031)
3.2.2.2 Global Transdermal Patch Revenue Market Share by Application (2020-2031)
3.2.3 Transdermal Patch Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Methyl Salicylate-based Patch of Transdermal Patch Revenue Market Share by Application
3.3.2 Rivastigmine Transdermal Patch of Transdermal Patch Revenue Market Share by Application
3.3.3 Fentanyl Transdermal Patch of Transdermal Patch Revenue Market Share by Application
3.3.4 Lidocaine Patch of Transdermal Patch Revenue Market Share by Application
3.3.5 Diclofenac Patch of Transdermal Patch Revenue Market Share by Application
3.3.6 Nicotine Transdermal Patch of Transdermal Patch Revenue Market Share by Application
3.3.7 Others of Transdermal Patch Revenue Market Share by Application
4 Global Transdermal Patch by Manufacturers
4.1 Global Top Transdermal Patch Manufacturers by Sales (2020-2025)
4.1.1 Global Transdermal Patch Sales by Manufacturer (2020-2025)
4.1.2 Global Transdermal Patch Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Transdermal Patch Manufacturers by Revenue (2020-2025)
4.2.1 Global Transdermal Patch Revenue by Manufacturer (2020-2025)
4.2.2 Global Transdermal Patch Revenue Share by Manufacturer (2020-2025)
4.3 Global Transdermal Patch Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Transdermal Patch Manufacturers Covered: Ranking by Revenue
4.4.2 Global Transdermal Patch Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Transdermal Patch Manufacturing Base Distribution, Product Type
4.5.1 Transdermal Patch Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Transdermal Patch Market
4.5.3 Manufacturers Transdermal Patch Product Type and Application
4.5.4 Methyl Salicylate-based Patch Market Sales of Transdermal Patch by Manufacturer
4.5.5 Rivastigmine Transdermal Patch Market Sales of Transdermal Patch by Manufacturer
4.5.6 Fentanyl Transdermal Patch Market Sales of Transdermal Patch by Manufacturer
4.5.7 Lidocaine Patch Market Sales of Transdermal Patch by Manufacturer
4.5.8 Diclofenac Patch Market Sales of Transdermal Patch by Manufacturer
4.5.9 Nicotine Transdermal Patch Market Sales of Transdermal Patch by Manufacturer
4.5.10 Others Market Sales of Transdermal Patch by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Hisamitsu Pharmaceutical
5.1.1 Hisamitsu Pharmaceutical Company Information
5.1.2 Hisamitsu Pharmaceutical Description, Business Overview
5.1.3 Hisamitsu Pharmaceutical Transdermal Patch Products Offered
5.1.4 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Hisamitsu Pharmaceutical Transdermal Patch Sales by Product in 2024
5.1.6 Hisamitsu Pharmaceutical Transdermal Patch Sales by Application in 2024
5.1.7 Hisamitsu Pharmaceutical Transdermal Patch Sales by Geographic Area in 2024
5.1.8 Hisamitsu Pharmaceutical Recent Developments
5.2 Johnson & Johnson
5.2.1 Johnson & Johnson Company Information
5.2.2 Johnson & Johnson Description, Business Overview
5.2.3 Johnson & Johnson Transdermal Patch Products Offered
5.2.4 Johnson & Johnson Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Johnson & Johnson Transdermal Patch Sales by Product in 2024
5.2.6 Johnson & Johnson Transdermal Patch Sales by Application in 2024
5.2.7 Johnson & Johnson Transdermal Patch Sales by Geographic Area in 2024
5.2.8 Johnson & Johnson Recent Developments
5.3 Novartis
5.3.1 Novartis Company Information
5.3.2 Novartis Description, Business Overview
5.3.3 Novartis Transdermal Patch Products Offered
5.3.4 Novartis Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Novartis Transdermal Patch Sales by Product in 2024
5.3.6 Novartis Transdermal Patch Sales by Application in 2024
5.3.7 Novartis Transdermal Patch Sales by Geographic Area in 2024
5.3.8 Novartis Recent Developments
5.4 UCB Pharma
5.4.1 UCB Pharma Company Information
5.4.2 UCB Pharma Description, Business Overview
5.4.3 UCB Pharma Transdermal Patch Products Offered
5.4.4 UCB Pharma Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.4.5 UCB Pharma Transdermal Patch Sales by Product in 2024
5.4.6 UCB Pharma Transdermal Patch Sales by Application in 2024
5.4.7 UCB Pharma Transdermal Patch Sales by Geographic Area in 2024
5.4.8 UCB Pharma Recent Developments
5.5 Mylan
5.5.1 Mylan Company Information
5.5.2 Mylan Description, Business Overview
5.5.3 Mylan Transdermal Patch Products Offered
5.5.4 Mylan Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Mylan Transdermal Patch Sales by Product in 2024
5.5.6 Mylan Transdermal Patch Sales by Application in 2024
5.5.7 Mylan Transdermal Patch Sales by Geographic Area in 2024
5.5.8 Mylan Recent Developments
5.6 Teva Pharmaceutical
5.6.1 Teva Pharmaceutical Company Information
5.6.2 Teva Pharmaceutical Description, Business Overview
5.6.3 Teva Pharmaceutical Transdermal Patch Products Offered
5.6.4 Teva Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Teva Pharmaceutical Transdermal Patch Sales by Product in 2024
5.6.6 Teva Pharmaceutical Transdermal Patch Sales by Application in 2024
5.6.7 Teva Pharmaceutical Transdermal Patch Sales by Geographic Area in 2024
5.6.8 Teva Pharmaceutical Recent Developments
5.7 Nitto Denko
5.7.1 Nitto Denko Company Information
5.7.2 Nitto Denko Description, Business Overview
5.7.3 Nitto Denko Transdermal Patch Products Offered
5.7.4 Nitto Denko Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Nitto Denko Transdermal Patch Sales by Product in 2024
5.7.6 Nitto Denko Transdermal Patch Sales by Application in 2024
5.7.7 Nitto Denko Transdermal Patch Sales by Geographic Area in 2024
5.7.8 Nitto Denko Recent Developments
5.8 Grünenthal
5.8.1 Grünenthal Company Information
5.8.2 Grünenthal Description, Business Overview
5.8.3 Grünenthal Transdermal Patch Products Offered
5.8.4 Grünenthal Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Grünenthal Transdermal Patch Sales by Product in 2024
5.8.6 Grünenthal Transdermal Patch Sales by Application in 2024
5.8.7 Grünenthal Transdermal Patch Sales by Geographic Area in 2024
5.8.8 Grünenthal Recent Developments
5.9 IBSA Group
5.9.1 IBSA Group Company Information
5.9.2 IBSA Group Description, Business Overview
5.9.3 IBSA Group Transdermal Patch Products Offered
5.9.4 IBSA Group Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.9.5 IBSA Group Transdermal Patch Sales by Product in 2024
5.9.6 IBSA Group Transdermal Patch Sales by Application in 2024
5.9.7 IBSA Group Transdermal Patch Sales by Geographic Area in 2024
5.9.8 IBSA Group Recent Developments
5.10 GSK
5.10.1 GSK Company Information
5.10.2 GSK Description, Business Overview
5.10.3 GSK Transdermal Patch Products Offered
5.10.4 GSK Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.10.5 GSK Transdermal Patch Sales by Product in 2024
5.10.6 GSK Transdermal Patch Sales by Application in 2024
5.10.7 GSK Transdermal Patch Sales by Geographic Area in 2024
5.10.8 GSK Recent Developments
5.11 Luye Pharma Group
5.11.1 Luye Pharma Group Company Information
5.11.2 Luye Pharma Group Description, Business Overview
5.11.3 Luye Pharma Group Transdermal Patch Products Offered
5.11.4 Luye Pharma Group Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Luye Pharma Group Transdermal Patch Sales by Product in 2024
5.11.6 Luye Pharma Group Transdermal Patch Sales by Application in 2024
5.11.7 Luye Pharma Group Transdermal Patch Sales by Geographic Area in 2024
5.11.8 Luye Pharma Group Recent Developments
5.12 Pfizer
5.12.1 Pfizer Company Information
5.12.2 Pfizer Description, Business Overview
5.12.3 Pfizer Transdermal Patch Products Offered
5.12.4 Pfizer Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Pfizer Transdermal Patch Sales by Product in 2024
5.12.6 Pfizer Transdermal Patch Sales by Application in 2024
5.12.7 Pfizer Transdermal Patch Sales by Geographic Area in 2024
5.12.8 Pfizer Recent Developments
5.13 Chattem
5.13.1 Chattem Company Information
5.13.2 Chattem Description, Business Overview
5.13.3 Chattem Transdermal Patch Products Offered
5.13.4 Chattem Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Chattem Transdermal Patch Sales by Product in 2024
5.13.6 Chattem Transdermal Patch Sales by Application in 2024
5.13.7 Chattem Transdermal Patch Sales by Geographic Area in 2024
5.13.8 Chattem Recent Developments
5.14 Dr Reddy’s Laboratories
5.14.1 Dr Reddy’s Laboratories Company Information
5.14.2 Dr Reddy’s Laboratories Description, Business Overview
5.14.3 Dr Reddy’s Laboratories Transdermal Patch Products Offered
5.14.4 Dr Reddy’s Laboratories Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.14.5 Dr Reddy’s Laboratories Transdermal Patch Sales by Product in 2024
5.14.6 Dr Reddy’s Laboratories Transdermal Patch Sales by Application in 2024
5.14.7 Dr Reddy’s Laboratories Transdermal Patch Sales by Geographic Area in 2024
5.14.8 Dr Reddy’s Laboratories Recent Developments
5.15 Bayer
5.15.1 Bayer Company Information
5.15.2 Bayer Description, Business Overview
5.15.3 Bayer Transdermal Patch Products Offered
5.15.4 Bayer Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.15.5 Bayer Transdermal Patch Sales by Product in 2024
5.15.6 Bayer Transdermal Patch Sales by Application in 2024
5.15.7 Bayer Transdermal Patch Sales by Geographic Area in 2024
5.15.8 Bayer Recent Developments
5.16 Mundipharma
5.16.1 Mundipharma Company Information
5.16.2 Mundipharma Description, Business Overview
5.16.3 Mundipharma Transdermal Patch Products Offered
5.16.4 Mundipharma Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.16.5 Mundipharma Transdermal Patch Sales by Product in 2024
5.16.6 Mundipharma Transdermal Patch Sales by Application in 2024
5.16.7 Mundipharma Transdermal Patch Sales by Geographic Area in 2024
5.16.8 Mundipharma Recent Developments
5.17 Endo International
5.17.1 Endo International Company Information
5.17.2 Endo International Description, Business Overview
5.17.3 Endo International Transdermal Patch Products Offered
5.17.4 Endo International Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.17.5 Endo International Transdermal Patch Sales by Product in 2024
5.17.6 Endo International Transdermal Patch Sales by Application in 2024
5.17.7 Endo International Transdermal Patch Sales by Geographic Area in 2024
5.17.8 Endo International Recent Developments
5.18 Beijing Tide Pharmaceutical
5.18.1 Beijing Tide Pharmaceutical Company Information
5.18.2 Beijing Tide Pharmaceutical Description, Business Overview
5.18.3 Beijing Tide Pharmaceutical Transdermal Patch Products Offered
5.18.4 Beijing Tide Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2020-2025)
5.18.5 Beijing Tide Pharmaceutical Transdermal Patch Sales by Product in 2024
5.18.6 Beijing Tide Pharmaceutical Transdermal Patch Sales by Application in 2024
5.18.7 Beijing Tide Pharmaceutical Transdermal Patch Sales by Geographic Area in 2024
5.18.8 Beijing Tide Pharmaceutical Recent Developments
6 North America
6.1 North America Transdermal Patch Market Size YoY Growth 2020-2031
6.2 North America Transdermal Patch Market Facts & Figures by Country
6.2.1 North America Transdermal Patch Sales by Country (2020-2031)
6.2.2 North America Transdermal Patch Revenue by Country (2020-2031)
6.3 North America Transdermal Patch Sales by Type (2020-2025)
6.4 North America Transdermal Patch Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Transdermal Patch Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Transdermal Patch Market Facts & Figures by Region
7.2.1 Asia-Pacific Transdermal Patch Sales by Region (2020-2031)
7.2.2 Asia-Pacific Transdermal Patch Revenue by Region (2020-2031)
7.3 Asia-Pacific Transdermal Patch Sales by Type (2020-2025)
7.4 Asia-Pacific Transdermal Patch Sales by Application (2020-2025)
8 Europe
8.1 Europe Transdermal Patch Market Size YoY Growth 2020-2031
8.2 Europe Transdermal Patch Market Facts & Figures by Country
8.2.1 Europe Transdermal Patch Sales by Country (2020-2031)
8.2.2 Europe Transdermal Patch Revenue by Country (2020-2031)
8.3 Europe Transdermal Patch Sales by Type (2020-2025)
8.4 Europe Transdermal Patch Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Transdermal Patch Market Size YoY Growth 2020-2031
9.2 Latin America Transdermal Patch Market Facts & Figures by Country
9.2.1 Latin America Transdermal Patch Sales by Country (2020-2031)
9.2.2 Latin America Transdermal Patch Revenue by Country (2020-2031)
9.3 Latin America Transdermal Patch Sales by Type (2020-2025)
9.4 Latin America Transdermal Patch Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Transdermal Patch Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Transdermal Patch Market Facts & Figures by Country
10.2.1 Middle East and Africa Transdermal Patch Sales by Country (2020-2031)
10.2.2 Middle East and Africa Transdermal Patch Revenue by Country (2020-2031)
10.3 Middle East and Africa Transdermal Patch Sales by Type (2020-2025)
10.4 Middle East and Africa Transdermal Patch Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Transdermal Patch Supply Chain Analysis
11.2 Transdermal Patch Key Raw Materials and Upstream Suppliers
11.3 Transdermal Patch Clients Analysis
11.4 Transdermal Patch Sales Channel and Sales Model Analysis
11.4.1 Transdermal Patch Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Transdermal Patch Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Transdermal Patch Distributors
12 Transdermal Patch Market Dynamics
12.1 Transdermal Patch Industry Trends
12.2 Transdermal Patch Market Drivers
12.3 Transdermal Patch Market Challenges
12.4 Transdermal Patch Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD(transdermal patch)の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2025/05/22 10:26

144.36 円

163.90 円

196.50 円

ページTOPに戻る